CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) of $98.00 thousand for the 12-month period ending 2012-12-29, per its 10-K filed 2013-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTax · last filed 2013-02-27
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for the quarter ending 2012-12-29 was $196.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for the quarter ending 2012-09-29 was -$60.00K, a 113.16% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $51.00K, a 83.71% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was -$89.00K, a 234.85% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for fiscal 2012 was $98.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for fiscal 2011 was -$820.00K, a 115.42% decline from fiscal 2010.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for fiscal 2010 was $5.32M.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-29 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $136.00K derived: sum of 2 quarters · filed 2013-02-27 | $187.00K derived: sum of 3 quarters · filed 2013-02-27 | $98.00K 10-K · filed 2013-02-27 |
| 2012-09-29 | -$60.00K 10-Q · filed 2012-11-01 | -$9.00K derived: sum of 2 quarters · filed 2012-11-01 | -$98.00K 10-Q · filed 2012-11-01 | -$1.75M derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-06-30 | $51.00K 10-Q · filed 2012-08-07 | -$38.00K 10-Q · filed 2012-08-07 | -$1.69M derived: sum of 3 quarters · filed 2013-02-27 | -$1.24M derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-03-31 | -$89.00K 10-Q · filed 2012-05-04 | -$1.74M derived: sum of 2 quarters · filed 2013-02-27 | -$1.29M derived: sum of 3 quarters · filed 2013-02-27 | -$975.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$1.20M derived: sum of 2 quarters · filed 2013-02-27 | -$886.00K derived: sum of 3 quarters · filed 2013-02-27 | -$820.00K 10-K · filed 2013-02-27 |
| 2011-09-24 | $456.00K 10-Q · filed 2012-11-01 | $769.00K derived: sum of 2 quarters · filed 2012-11-01 | $835.00K 10-Q · filed 2012-11-01 | |
| 2011-06-25 | $313.00K 10-Q · filed 2012-08-07 | $379.00K 10-Q · filed 2012-08-07 | ||
| 2011-03-26 | $66.00K 10-Q · filed 2012-05-04 | |||
| 2010-12-25 | $5.32M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |